Psoriasis is an inflammatory skin condition characterized by hyperproliferating keratinocytes, aberrant epidermal differentiation, and infiltrating inflammatory cells. Traditional herbal medicine has been used extensively to treat psoriasis with promising clinical results. Due to the vast number of herbal preparations used all over the world, we have focused on curcumin, indigo naturalis (IN), and aloe vera (AV) because they are the most commonly reported herbal therapeutics.
Objective
This review illustrates the beneficial effects of multiple herbal medications as a therapeutic alternative in the treatment of psoriasis.
Methods
A thorough literature search of the PubMed database was conducted to identify psoriasis studies utilizing these three herbs as therapeutics.
Results
Curcumin has been demonstrated to be a TNFα blocker. IN has been effective in treating plaque and nail psoriasis. AV-treated psoriasis also has shown clinical improvement.
Conclusion
Further studies are needed to back up these claims before these formulations can be accepted into the current treatment regimens.
ButlerM.S.The role of natural product chemistry in drug discovery. J Nat Prod.2004. 67(12): 2141–53.
2.
BalunasM.J., KinghornA.D.Drug discovery from medicinal plants. Life Sci.2005. 78(5): 431–41.
3.
Gurib-FakimA.Medicinal plants: traditions of yesterday and drugs of tomorrow. Mol Aspects Med.2006. 27(1): 1–93.
4.
NewmanD.J., CraggG.M.Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod.2012. 75(3): 311–35.
5.
CraggG.M., NewmanD.J.Natural products: a continuing source of novel drug leads. Biochim Biophys Acta.2013. 1830(6): 3670–95.
6.
SenT., SamantaS.K.Medicinal Plants, Human Health and Biodiversity: A Broad Review. Adv Biochem Eng Biotechnol.2015; 147: 59–110.
7.
AggarwalB.B., KumarA., BhartiA.C.Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res.2003. 23(1A): 363–98.
8.
AmmonH.P., WahlM.A.Pharmacology of Curcuma longa. Planta Med.1991. 57(1): 1–7.
9.
BrouetI., OhshimaH.Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem Biophys Res Commun.1995. 206(2): 533–40.
10.
DikshitM., RastogiL., ShuklaR., SrimalR.C.Prevention of ischaemiainduced biochemical changes by curcumin & quinidine in the cat heart. Indian J Med Res.1995. 101: 31–5.
GunesH., GulenD., MutluR., GumusA., TasT., Eren TopkayaA.Antibacterial effects of curcumin: an in vitro minimum inhibitory concentration study. Toxicol Ind Health.2013.
13.
SinghR.K., RaiD., YadavD.Synthesis, antibacterial and antiviral properties of curcumin bioconjugates bearing dipeptide, fatty acids and folic acid. Eur J Med Chem.2010. 45(3): 1078–86.
14.
KimM.K., ChoiG.J., LeeH.S.Fungicidal property of Curcuma longa L. rhizome-derived curcumin against phytopathogenic fungi in a greenhouse. J Agric Food Chem.2003. 51(6): 1578–81.
15.
RaoC.V., RivensonA., SimiB., ReddyB.S.Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res.1995. 55(2): 259–66.
16.
LimtrakulP., LipigorngosonS., NamwongO., ApisariyakulA., DunnF.W.Inhibitory effect of dietary curcumin on skin carcinogenesis in mice. Cancer Lett.1997. 116(2): 197–203.
17.
ChoonhakarnC., BusaracomeP., SripanidkulchaiB., SarakarnP.A prospective, randomized clinical trial comparing topical aloe vera with 0.1% triamcinolone acetonide in mild to moderate plaque psoriasis. J Eur Acad Dermatol Venereol.2010. 24(2): 168–72.
18.
ReddyS., AggarwalB.B.Curcumin is a non-competitive and selective inhibitor of phosphorylase kinase. FEBS Lett.1994. 341(1): 19–22.
19.
HengM.C., SongM.K., HarkerJ., HengM.K.Drug-induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical, histological and immunohistochemical parameters. Br J Dermatol.2000. 143(5): 937–49.
20.
KurdS.K., SmithN., VanVoorheesA.Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: A prospective clinical trial. J Am Acad Dermatol.2008. 58(4): 625–31.
21.
GrantK.L., SchneiderC.D.Turmeric. Am J Health Syst Pharm.2000. 57(12): 1121–2.
22.
IresonC.R., JonesD.J., OrrS.Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomarkers Prev.2002. 11(1): 105–11.
23.
VerucchiG., CalzaL., AttardL., ChiodoF.Acute hepatitis induced by traditional Chinese herbs used in the treatment of psoriasis. J Gastroenterol Hepatol.2002. 17(12): 1342–3.
24.
LinY.K., SeeL.C., HuangY.H.Comparison of refined and crude indigo naturalis ointment in treating psoriasis: randomized, observer-blind, controlled, intrapatient trial. Arch Dermatol.2012. 148(3): 397–400.
25.
LinY.K., SeeL.C., ChangY.C.Treatment of psoriatic nails with indigo naturalis oil extract: a non-controlled pilot study. Dermatology.2011. 223(3): 239–43.
26.
LinY.K., SeeL.C., HuangY.H.Efficacy and safety of Indigo naturalis extract in oil (Lindioil) in treating nail psoriasis: a randomized, observer-blind, vehicle-controlled trial. Phytomedicine.2014. 21(7): 1015–20.
27.
LinY.K.Indigo naturalis oil extract drops in the treatment of moderate to severe nail psoriasis: a small case series. Arch Dermatol.2011. 147(5): 627–9.
28.
LinY.K., ChangC.J., ChangY.C., WongW.R., ChangS.C., PangJ.H.Clinical assessment of patients with recalcitrant psoriasis in a randomized, observer-blind, vehicle-controlled trial using indigo naturalis. Arch Dermatol.2008. 144(11): 1457–64.
29.
LinY.K., WongW.R., ChangY.C.The efficacy and safety of topically applied indigo naturalis ointment in patients with plaque-type psoriasis. Dermatology.2007. 214(2): 155–61.
30.
LinY.K., YenH.R., WongW.R., YangS.H., PangJ.H.Successful treatment of pediatric psoriasis with Indigo naturalis composite ointment. Pediatr Dermatol.2006. 23(5): 507–10.
31.
LinY.K., WongW.R., Su PangJ.H.Successful treatment of recalcitrant psoriasis with Indigo naturalis ointment. Clin Exp Dermatol.2007. 32(1): 99–100.
32.
SyedT.A., AhmadS.A., HoltA.H.Management of psoriasis with Aloe vera extract in a hydrophilic cream: a placebo-controlled, double-blind study. Trop Med Int Health.1996. 1(4): 505–9.
33.
PaulsenE., KorsholmL., BrandrupF.A double-blind, placebo-controlled study of a commercial Aloe vera gel in the treatment of slight to moderate psoriasis vulgaris. J Eur Acad Dermatol Venereol.2005. 19(3): 326–31.
34.
GreavesM.W., WeinsteinG.D.Treatment of psoriasis. N Engl J Med.1995. 332(9): 581–8.
35.
KurdS.K., RichardsonS.K., GelfandJ.M.Update on the epidemiology and systemic treatment of psoriasis. Expert Rev Clin Immunol.2007. 3(2): 171–85.
36.
FleischerA.B.Jr., FeldmanS.R., RappS.R.Alternative therapies commonly used within a population of patients with psoriasis. Cutis.1996. 58(3): 216–20.
37.
TonnesenH.H., de VriesH., KarlsenJ., Beijersbergen van HenegouwenG.Studies on curcumin and curcuminoids. IX: Investigation of the photobiological activity of curcumin using bacterial indicator systems. J Pharm Sci.1987. 76(5): 371–3.
38.
BosmanB.Testing of lipoxygenase inhibitors, cyclooxygenase inhibitors, drugs with immunomodulating properties and some reference antipsoriatic drugs in the modified mouse tail test, an animal model of psoriasis. Skin Pharmacol.1994. 7(6): 324–34.
39.
ChoJ.W., LeeK.S., KimC.W.Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets. Int J Mol Med.2007. 19(3): 469–74.
40.
PolA., BergersM., SchalkwijkJ.Comparison of antiproliferative effects of experimental and established antipsoriatic drugs on human keratinocytes, using a simple 96-well-plate assay. In Vitro Cell Dev Biol Anim.2003. 39(1-2): 36–42.
41.
SunJ., HanJ., ZhaoY., ZhuQ., HuJ.Curcumin induces apoptosis in tumor necrosis factor-alpha-treated HaCaT cells. Int Immunopharmacol.2012. 13(2): 170–4.
42.
ReddyA.C., LokeshB.R.Effect of curcumin and eugenol on iron-induced hepatic toxicity in rats. Toxicology.1996. 107(1): 39–45.
43.
CohenP.The role of cyclic-AMP-dependent protein kinase in the regulation of glycogen metabolism in mammalian skeletal muscle. Curr Top Cell Regul.1978. 14: 117–96.
44.
CohenP.The role of protein phosphorylation in neural and hormonal control of cellular activity. Nature.1982. 296(5858): 613–20.
45.
HengM.C., SongM.K., HengM.K.Elevated phosphorylase kinase activity in psoriatic epidermis: correlation with increased phosphorylation and psoriatic activity. Br J Dermatol.1994. 130(3): 298–306.
46.
HarmannB., ZanderN.F., KilimannM.W.Isoform diversity of phosphorylase kinase alpha and beta subunits generated by alternative RNA splicing. J Biol Chem.1991. 266(24): 15631–7.
47.
LinY.K., LeuY.L., YangS.H., ChenH.W., WangC.T., PangJ.H.Anti-psoriatic effects of indigo naturalis on the proliferation and differentiation of keratinocytes with indirubin as the active component. J Dermatol Sci.2009. 54(3): 168–74.
48.
LinY.K., LeuY.L., HuangT.H.Anti-inflammatory effects of the extract of indigo naturalis in human neutrophils. J Ethnopharmacol.2009. 125(1): 51–8.
49.
ChangH.N., PangJ.H., YangS.H.Inhibitory effect of indigo naturalis on tumor necrosis factor-alpha-induced vascular cell adhesion molecule-1 expression in human umbilical vein endothelial cells. Molecules.2010. 15(9): 6423–35.
